When a patient checks in to a hospital, they naturally expect to receive safe and effective treatment options and medical services. Unfortunately, a drug or agent can be dangerous even with FDA approval. For example, various medical experts and radiologists have been debating the safety of gadolinium-based contrast agents (GBCAs) after a critical study was released back in 2014. These dyes, which contain a metal called gadolinium, are injected into the patient’s body during a magnetic resonance imaging (MRI) exam. However, this agent doesn’t naturally dissipate after the procedure; in fact, it’s retained in the brain, potential harming a patient’s overall health.
GBCAs have been associated with Nephrogenic Systemic Fibrosis, Gadolinium deposition disease, and other painful or dangerous side-effects. If you or someone you love has suffered any medical complications after an MRI exam, contact Wagner Reese. Most patients face a seemingly insurmountable wall of professional disbelief and denial whenever they try to explain their symptoms and fears to medical professionals. They often feel helpless, confused, and frustrated whenever they have to pay additional medical expenses to these doctors who pointedly ignore their concerns. We can offer you the support you deserve in your time of need. Our trial-tested attorneys can research your case and help you take a stand against any negligent parties. For our 20 years, our legal team has been litigating on behalf of people who have been injured by defective drugs and faulty medical devices. We have the skills and experience to help you recover damages that facilitate your recovery and safeguard your quality of life.
Learn more about what our firm can do for you. Call (888) 204-8440 to discuss your case with our Indiana defective medical device lawyers.
The Symptoms of Gadolinium Toxicity
For the last 30 years, doctors have been using GBCAs to improve the clarity and quality of MRI scans. This dye improves the accuracy of the exam by giving radiologists a clearer image of the body’s internal structures. Usually, a technologist or nurse will let you know if a GBCA will be injected prior to your examination. As the patient, you have a legal right to seek additional information or advice before being injected with this agent.
The symptoms commonly associated with gadolinium toxicity often appear at an acute level after the initial MRI. As years pass, these symptoms develop into chronic medical conditions that warrant additional testing and treatments.
Post-MRI gadolinium toxicity symptoms may include:
- Thyroid abnormalities
- Adrenal fatigue
- Mast cell problems
- Renal failure
- “Brain fog”
- Intense headaches
- Burning or “Skin crawling” sensation
- Bone or joint pain
- Itchy skin
- Weak muscles
- Hair loss
- Worsening vision
- Dry or bloodshot eyes
- Cognitive symptoms
- Balancing problems
Current research states that there are few differences between early and ongoing symptoms. In fact, most symptoms appear within the first month of the MRI, with many victims noticing serious issues mere hours or days after the exam. Depending on the patient, the intensity of these symptoms can either subside or increase with time. At present, there is no cure for gadolinium toxicity. A patient suffering from chronic symptoms can only rely on pain-relieving treatments as the gadolinium continues to impact their body.
In 2017, actor Chuck Norris spread awareness about gadolinium toxicity when he failed a $10 million lawsuit against a contrast vendor and distributor for allegedly poisoning his wife. According to the lawsuit, Gena Norris contracted “gadolinium deposition disease” after enduring several MRI exams. In light of the lawsuit, the FDA’s Medical Imaging Drugs Advisory Committee voted to put new labels on GBCAs to warn the public about the possibility of gadolinium retention. The FDA also admitted that gadolinium can linger in the body “for months or years,” and ordered manufacturers to conduct additional clinical studies to assess the safety of GBCAs.
Pursue Damages Today
If you’re suffering medical complications associated with GBCAs, contact the Indiana personal injury lawyers at Wagner Reese. Manufacturers and medical professionals have an obligation to provide patients tested, safe, and effective drugs. Also, a patient deserves to know the side-effects and potential dangers associated with GBCAs before agreeing to be injected. By taking legal action, you may be able to recover damages that help you afford your existing and projected medical expenses. As a law firm, we take pride in helping our clients pursue justice and restitution. If you’re ready to hold the negligent party accountable for your condition, turn to an experienced personal injury law firm today.
Contact Wagner Reese at (888) 204-8440 to schedule a free consultation.